Related Experiment Video
Updated: Jul 3, 2026

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
Published on: November 26, 2015
Clinical effectiveness of ototopical application of mupirocin ointment in methicillin-resistant Staphylococcus aureus
Masayuki Furukawa1, Akira Minekawa, Takuo Haruyama
1Department of Otorhinolaryngology, Juntendo University School of Medicine, Tokyo, Japan.
Objective:
Methicillin-resistant Staphylococcus aureus (MRSA) otorrhea has become an increasing problem with regard to infection through the tympanic membrane perforation and postsurgical infection. In particular, dry ear, at the preoperative stage, is considered to be a crucial factor in surgery. We evaluated how to control MRSA otorrhea before and after ear surgery.
Patients And Methods:
Twenty-six patients having MRSA otorrhea were enrolled in the present study and randomly divided into 2 groups, namely, mupirocin ointment therapy for 16 patients and ofloxacin ear drops for 10 patients. Approximately 0.6 mg of mupirocin ointment was administered locally to the tympanic membrane and the promontory around and through the perforation with its adjacent external ear canal 1 to 4 times for 2 or 3 weeks at the clinic. On the other hand, ofloxacin ear drops were administered daily by the patients for 2 or 3 weeks at home.
Results:
Complete elimination of MRSA from the ear was obtained in all patients of the mupirocin group. This showed a significant improvement (p < 0.001) as compared with the ofloxacin group (improvement + cure rate, 40%). Local application of mupirocin did not aggravate hearing acuity of any patients who were evaluated by pure-tone audiometry before and after treatment.
Conclusion:
The present findings first indicate that minimally essential application of mupirocin ointment is an extremely useful ototopical agent against MRSA otorrhea without ototoxicity.
Insights
Mupirocin ointment effectively eliminated Methicillin-resistant Staphylococcus aureus (MRSA) in ear infections, showing superior results compared to ofloxacin ear drops. This treatment is a safe and useful option for MRSA otorrhea without causing hearing loss.
Area of Science:
- Otolaryngology
- Infectious Diseases
- Microbiology
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) otorrhea is a growing concern, particularly with tympanic membrane perforations and post-surgical infections.
- Preoperative dry ear conditions are critical factors influencing surgical outcomes in otorrhea cases.
Purpose of the Study:
- To evaluate the efficacy of mupirocin ointment versus ofloxacin ear drops in controlling MRSA otorrhea.
- To assess the safety and effectiveness of ototopical treatments for MRSA ear infections before and after surgery.
Main Methods:
- A randomized study involving 26 patients with MRSA otorrhea.
- Mupirocin ointment applied locally (1-4 times over 2-3 weeks) vs. ofloxacin ear drops administered daily at home for 2-3 weeks.
Main Results:
- Complete eradication of MRSA was achieved in 100% of patients treated with mupirocin ointment.
- Mupirocin showed significantly higher improvement and cure rates (p < 0.001) compared to ofloxacin (40% improvement + cure rate).
- Pure-tone audiometry confirmed no adverse effects on hearing acuity with mupirocin treatment.
Conclusions:
- Minimally essential local application of mupirocin ointment is a highly effective ototopical agent for MRSA otorrhea.
- Mupirocin demonstrates excellent efficacy against MRSA otorrhea with no evidence of ototoxicity.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Staphylococcal Skin Infections
Microbiome of the Eye
Mechanism of Antibiotic Resistance in MRSA
Ophthalmic Drug Delivery Systems
Hand hygiene
Hand washing...

